Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

bmiMD vs TRYM Health

By GLP-1 ScorecardUpdated

bmiMDFactor scores not reassessed.
Site position #27

Higher score

TRYM HealthFactor scores not reassessed.
Site position #114

Lower score

Score comparison

bmiMD has the higher recorded score — 79.2/100 to 70.6/100.

bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.

Before you choose

Before comparing the headline prices, the bmiMD review and the TRYM Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, bmiMD vs Tyde Wellness and Candor Rx vs TRYM Health compare each of them with another graded program, and the list of alternatives to bmiMD ranks the programs closest to bmiMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueTRYM Health +8
88
96
Dose & formulationbmiMD +10
82
72
Clinical oversightbmiMD +15
70
55
Labs & monitoringbmiMD +19
72
53
FulfillmentbmiMD +10
84
74
Contract termsbmiMD +19
74
55
bmiMD · top barTRYM Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricbmiMDTRYM Health
WeighScore79.2/10070.6/100
GradeC+C
Site position#27#114
Semaglutide$129/mo on the one-month plan ($99/mo equivalent with $1,188 prepaid for 12 months)$96/mo (all doses, compounded)
Tirzepatide$179/mo on the one-month plan ($139/mo equivalent with $1,668 prepaid for 12 months)$126/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesNot confirmed
bmiMD

Site position #27 · C+

Factor scores not reassessed.

Strengths

  • Advertises the same price across prescribed doses for each selected injection plan
  • Publishes compounded semaglutide and tirzepatide injection plans
  • Every rung of both ladders is published with the total charge beside each per-month figure
  • All 50 states

What to consider

  • The pricing block opens on the 3-Month tab, so the figure a reader meets first is a commitment rate rather than a month
  • The annual $99 and $139 monthly equivalents require $1,188 or $1,668 paid upfront for 12 months
  • A higher $229 and $349 monthly figure is printed beside every plan price under a standing LIMITED TIME label, with no published basis
  • Neither the compounding pharmacy nor the prescribing group is named on the product pages
TRYM Health

Site position #114 · C

Factor scores not reassessed.

FDAWarning letter issued to TRYM Health, Inc. dba TRYM Health in September 2025. See the FDA warning-letter database.

Strengths

  • Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
  • Available in all 50 states with free shipping and FSA/HSA eligibility
  • Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
  • Temperature-controlled insulated shipping and flexible cancellation

What to consider

  • Compounding pharmacy partner not named
  • LegitScript certification was not documented on the public pages reviewed
  • Lowest per-day pricing likely requires a longer prepaid plan commitment
  • Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named
  • FDA issued TRYM Health, Inc. dba TRYM Health a warning letter in September 2025; the letter is public in FDA's warning-letter database

Featured provider

bmiMD

Factor scores not reassessed.

bmiMD scores 79.2/100 (C+). bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard